Olga Petrovna Shatova

Dr. Olga Petrovna Shatova

NI Pirogov Russian National Research Medical University, Moscow, Moskva, Russia

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2022 in Journal of Nutrition and Metabolism
Verified
Journal Article
Open access
PDF file
AZAnastasia A. Zabolotneva
Anastasia A. Zabolotneva
OSOlga Petrovna Shatova
Olga Petrovna Shatova
AKAnastasia Kotikova
Anastasia Kotikova
ASAleksandr V. Shestopalov
Aleksandr V. Shestopalov
SRSergei A. Roumiantsev
Sergei A. Roumiantsev
The investigation of alkylresorcinols has drawn an increasing interest recently. Alkylresorcinols (ARs) are natural chemical compounds synthesized by bacteria, fungi, sponges, and higher plants, possessing a lipophilic polyphenol structures and a myriad of biological properties. Human takes ARs as a component of a whole grain diet (from whole grain rye, wheat, and barley products), and thus, alkylresorcinols are frequently used as whole grain intake markers. Besides, ARs are considered as promising bioregulators of metabolic and immune processes, as well as adjuvant therapeutic agents for antimicrobial and anticancer treatment. In this review, we attempted to systematize the accumulated information concerning ARs origin, metabolism, biological properties, and their effect on human health.

17 April 2023 in Biology Bulletin Reviews
Verified
Journal Article
Closed access
PDF file
OSOlga Petrovna Shatova
Olga Petrovna Shatova
ASA. V. Shestopalov
A. V. Shestopalov
In modern scientific literature, close attention is paid to the biological role of tryptophan catabolites both in normal conditions and in various pathologies. There are more and more reports that tryptophan metabolism catabolites play a signaling role in the human body and in the intestinal microbial community. Receptors and signaling pathways in the human body, the so-called tryptophan signaling molecules (TrpSM), their cellular targets, and their physiological and metabolic effects are being actively studied. It has now been established that almost all catabolites of tryptophan metabolism are signaling molecules. Many of them realize their signaling role through arylhydrocarbon receptors (АhR). The dominant pathway of tryptophan metabolism for the human body is the kynurenine pathway, which is the source of universal the signaling molecules—kynurenine, quinolinic and kynurenic acids. The indole pathway of tryptophan catabolism, the main pathway for the microbiota, with the exception of indole formation reactions in immunocompetent cells, is a source of interregional and interspecies signaling molecules—indole and its derivatives: indole-3-pyruvate, indole-3-lactate, indole-3-acetate, indole-3-propionate, indole-3-acrylate, indole-3-butyrate and indole-3-acetaldehyde. Serotonin and melatonin are also universal signaling molecules and have been widely studied in various diseases of the nervous system.

20 September 2022 in Cancers
Verified
Journal Article
Open access
PDF file
PSPetr V. Shegay
Petr V. Shegay
AZAnastasia A. Zabolotneva
Anastasia A. Zabolotneva
OSOlga Petrovna Shatova
Olga Petrovna Shatova
ASAleksandr V. Shestopalov
Aleksandr V. Shestopalov
AKAndrei Kaprin
Andrei Kaprin
The role of lactic acid (lactate) in cell metabolism has been significantly revised in recent decades. Initially, lactic acid was attributed to the role of a toxic end-product of metabolism, with its accumulation in the cell and extracellular space leading to acidosis, muscle pain, and other adverse effects. However, it has now become obvious that lactate is not only a universal fuel molecule and the main substrate for gluconeogenesis but also one of the most ancient metabolites, with a signaling function that has a wide range of regulatory activity. The Warburg effect, described 100 years ago (the intensification of glycolysis associated with high lactate production), which is characteristic of many malignant tumors, confirms the key role of lactate not only in physiological conditions but also in pathologies. The study of lactate’s role in the malignant transformation becomes more relevant in the light of the “atavistic theory of carcinogenesis,” which suggests that tumor cells return to a more primitive hereditary phenotype during microevolution. In this review, we attempt to summarize the accumulated knowledge about the functions of lactate in cell metabolism and its role in the process of carcinogenesis and to consider the possible evolutionary significance of the Warburg effect.

3 January 2022 in Bulletin of Siberian Medicine
Verified
Journal Article
Open access
PDF file
ASAleksandr V. Shestopalov
Aleksandr V. Shestopalov
OSOlga Petrovna Shatova
Olga Petrovna Shatova
MKM. S. Karbyshev
M. S. Karbyshev
AGA. M. Gaponov
A. M. Gaponov
NMNatalia Moskaleva
Natalia Moskaleva
SRS. A. Roumiantsev
S. A. Roumiantsev
Aim. To assess the concentrations of bacterial and eukaryotic metabolites mainly involved in indole, kynurenine, and serotonin pathways of tryptophan metabolism in a cohort of patients with obesity. Materials and methods. Using high-performance liquid chromatography with mass spectrometric detection, the concentrations of several serum metabolites, such as kynurenine, kynurenic acid, anthranilic acid, xanthurenic acid, quinolinic acid, 5-hydroxyindole-3-acetate, tryptamine, serotonin, indole-3-lactate, indole-3-acetate, indole-3- butyrate, indole-3-carboxaldehyde, indole-3-acrylate, and indole-3-propionate, were analyzed in a cohort of obese patients compared with healthy volunteers.Results. It was found that serum levels of tryptophan metabolites of microbial and eukaryotic origin were significantly increased in obese patients. Therefore, the concentration of kynurenine in the blood serum in obese patients was 2,413 ± 855 nmol / l, while in healthy volunteers of the same age group, the level of kynurenine in the blood serum was 2,122 ± 863 nmol / l. In obese patients, two acids formed due to kynurenine metabolism; the concentrations of kynurenic and quinolinic acids were increased in the blood serum. The concentration of kynurenic acid in the blood serum in obese patients was 21.1 ± 9.26 nmol / l, and in healthy patients, it was 16.8 ± 8.37 nmol / l. At the same time, the level of quinolinic acid in the blood serum in obese patients was 73.1 ± 54.4 nmol / l and in healthy volunteers – 56.8 ± 34.1 nmol / l. Normally, the level of quinolinic acid is 3.4 times higher than the concentration of kynurenic acid, and in case of obesity, there is a comparable increase in these acids in the blood serum.From indole derivatives, mainly of microbial origin, the concentrations of indole-3-lactate, indole-3-butyrate, and indole-3-acetate were significantly increased in the blood serum of obese patients. In obese patients, the serum concentration of 5-hydroxyindole-3-acetate was elevated to 74.6 ± 75.8 nmol / l (in healthy volunteers – 59.4 ± 36.6 nmol / l); indole-3-lactate – to 523 ± 251 nmol / l (in healthy volunteers – 433 ± 208 nmol / l); indole-3-acetate – to 1,633 ± 1,166 nmol / l (in healthy volunteers – 1,186 ± 826 nmol / l); and indole-3-butyrate – to 4.61 ± 3.31 nmol / l (in healthy volunteers – 3.85 ± 2.51 nmol / l).Conclusion. In case of obesity, the utilization of tryptophan was intensified by both the microbiota population and the macroorganism. It was found that obese patients had higher concentrations of kynurenine, quinolinic and kynurenic acids, indole-3-acetate, indole-3-lactate, indole-3-butyrate, and 5-hydroxyindole-3-acetate. Apparently, against the background of increased production of proinflammatory cytokines by adipocytes in obese patients, the “kynurenine switch” was activated which contributed to subsequent overproduction of tryptophan metabolites involved in the immune function of the macroorganism.

1 March 2016 in Biomeditsinskaya Khimiya
Verified
Journal Article
Closed access
OSOlga Petrovna Shatova
Olga Petrovna Shatova
EBEu.V. Butenko
Eu.V. Butenko
EKEu.V. Khomutov
Eu.V. Khomutov
DKD.S. Kaplun
D.S. Kaplun
ISI.EU. Sedakov
I.EU. Sedakov
IZI.I. Zinkovych
I.I. Zinkovych
Large-scale epidemiological and clinical studies have demonstrated the efficacy of metformin in oncology practice. However, the mechanisms of implementation of the anti-tumor effect of this drug there is still need understanding. In this study we have investigated the effect of metformin on the activity of adenosine deaminase and respectively adenosinergic immunosuppression in tumors and their microenvironment. The material of the study was taken during surgery of breast cacer patients receiveing metformin, and also patients which did not take this drug. The adenosine deaminase activity and substrate (adenosine) and products (inosine, hypoxanthine) concentrations were determined by HPLC. Results of this study suggest that metformin significantly alters catabolism of purine nucleotides in the node breast adenocarcinoma tisue. However, the metformin-induced increase in the adenosine deaminase activity is not sufficient to reduce the level of adenosine in cancer tissue. Thus, in metformin treated patients the adenosine concentration remained unchanged, and inosine and hypoxanthine concentration significantly increased.

1 January 2021 in Problems of Biological, Medical and Pharmaceutical Chemistry
Verified
Journal Article
Closed access
ASAleksandr V. Shestopalov
Aleksandr V. Shestopalov
OSOlga Petrovna Shatova
Olga Petrovna Shatova
AZAnastasia A. Zabolotneva
Anastasia A. Zabolotneva
AGA.M. Gaponov
A.M. Gaponov
NMN.E. Moskaleva
N.E. Moskaleva
SRS.A. Roumiantsev
S.A. Roumiantsev